Filing Details

Accession Number:
0001209191-21-066004
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-22 07:30:39
Reporting Period:
2021-11-18
Accepted Time:
2021-11-22 07:30:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1579428 Axsome Therapeutics Inc. AXSM Pharmaceutical Preparations (2834) 454241907
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658379 Mark Coleman C/O Axsome Therapeutics, Inc.
22 Cortlandt Street, 16Th Floor
New York NY 10007
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-18 409 $35.07 421,407 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-11-18 1,021 $35.10 422,428 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,100 Direct
Footnotes
  1. Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
  2. Represents additional shares held directly by the reporting person prior to November 18, 2021.